526 related articles for article (PubMed ID: 10362821)
1. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
3. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
4. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
5. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
Yong M; Diener HC; Kaste M; Mau J
Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
[TBL] [Abstract][Full Text] [Related]
7. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
[TBL] [Abstract][Full Text] [Related]
8. Alteplase for acute ischemic stroke.
Gonzales NR; Grotta JC
Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
Feuerhake W; Chamorro H; Araya F
Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
[TBL] [Abstract][Full Text] [Related]
10. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
[TBL] [Abstract][Full Text] [Related]
11. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
12. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI
J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
[TBL] [Abstract][Full Text] [Related]
14. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Kobayashi K; Sakamoto Y
Eur Neurol; 2010; 63(6):331-6. PubMed ID: 20516694
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator for acute ischemic stroke.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
N Engl J Med; 1995 Dec; 333(24):1581-7. PubMed ID: 7477192
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.
Abu-Laban RB; Christenson JM; Innes GD; van Beek CA; Wanger KP; McKnight RD; MacPhail IA; Puskaric J; Sadowski RP; Singer J; Schechter MT; Wood VM
N Engl J Med; 2002 May; 346(20):1522-8. PubMed ID: 12015391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]